H.E. Abdul Rahman bin Mohammed Al Owais, UAE UAE Minister of Health and Prevention, signed a collaboration agreement with Leif Johansson, Chairman of leading global pharmaceutical firm AstraZeneca, as part of its strategy to boost the outcomes of nationwide indicators in the field of respiratory system conditions and also cancer, to attain the goals of the National Schedule 2021. The arrangement was signed presence of H.E. Dr. Muhammad Salim Al Olama, Undersecretary of the Ministry, assistant undersecretaries, and Samer Al Hallaq, Area Vice President at AstraZeneca.

The MoU aims to develop ingenious as well as integrated remedies to deal with asthma in children, along with participation in the field of respiratory system conditions according to the most recent global professional methods as well as using modern technologies to guarantee reliable management of the disease. It additionally includes cooperation in the area of cancer cells to develop clinical methods of international standards, to allow far better management of the illness throughout diagnosis, therapy and also to develop area understanding. The MoU additionally covers the advancement of diabetes care.

His Excellency Abdul Rahman Al Owais declared the strong calculated collaboration in between both events as well as the Ministry's eagerness to create regulations and also regulations in accordance with the wise management's directives, which permit worldwide medical companies to benefit from the affordable financial investment setting of the State. It likewise reinforces the efforts to achieve the UAE's worldwide management in the fostering of ingenious technologies such as artificial intelligence. H.E added that the Ministry stays eager to reinforce partnership with AstraZeneca as a calculated companion across a range of nationwide efforts and also projects that aim to achieve the Ministry's leading tactical goals in promoting community health and wellness.

H.E. Dr. Muhammad Salim Al Olama explained that the partnership with AstraZeneca adds to boosting the high quality of health care in the country, along with establishing an efficient and sustainable health and wellness system for a delighted culture. Such local as well as international partnerships assist improve the field of clinical research.

Leif Johansson, Head of AstraZeneca, said: We are committed to providing innovative solutions for patients and supporting the implementation of the National agenda and the UAE Vision 2021 through innovative projects, highlighting the global standards of the UAE health system. He added that the meeting with the UAE Minister of Health and Prevention and his distinguished team reflects a strong relationship between the Ministry and AstraZeneca.

Samer Al Hallaq, Vice Head Of State of the Middle East area as well as Head of the Gulf area for AstraZeneca, said that the projects and also efforts focus on individuals as well as their treatment as component of the national agenda. These efforts are targeted at building regional ability, supplying a thorough approach of treatment to enhance individual experiences, expand access to company medications and also to enhance understanding in oncology, diabetic issues, cardiovascular, along with respiratory departments.